{
    "xml": "<topic id=\"PHP2610\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/co-codamol\" basename=\"co-codamol\" title=\"CO-CODAMOL\">\n<title>CO-CODAMOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_59\" namespace=\"/interactions/list-of-drug-interactions/analgesics/paracetamol\">Paracetamol</xref>, <xref format=\"dita\" href=\"#bnf_int_88\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/codeine\">Codeine</xref>\n</p>\n<data name=\"vtmid\">412556009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_110392128\" title=\"Opioids\">Opioids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" title=\"OPIOIDS\" namespace=\"/drug-classes/opioids\">OPIOIDS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP48879\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/co-codamol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate pain (using co-codamol 8/500 preparations only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8/500&#8211;16/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 64/4000&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate pain (using co-codamol 15/500 preparations only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15/500&#8211;30/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 120/4000&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe pain (using co-codamol 30/500 preparations only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30/500&#8211;60/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 240/4000&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48917\" outputclass=\"importantSafetyInformation\" rev=\"1.8\" parent=\"/drugs/co-codamol\">\n<title>Important safety information</title>\n<body>\r\n<section>\r\n<sectiondiv>\r\n<p>See <xref format=\"dita\" href=\"#PHP460\" type=\"drug\" namespace=\"/drugs/codeine-phosphate\">codeine phosphate</xref> for MHRA/CHM advice for restrictions on the use of codeine as an analgesic in children.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP48929\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/co-codamol\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Acute ulcerative colitis</ph>; <ph outputclass=\"contraindication\">antibiotic-associated colitis</ph>; <ph outputclass=\"contraindication\">children under 18 years who undergo the removal of tonsils or adenoids for the treatment of obstructive sleep apnoea</ph>; <ph outputclass=\"contraindication\">conditions where abdominal distention develops</ph>; <ph outputclass=\"contraindication\">conditions where inhibition of peristalsis should be avoided</ph>; <ph outputclass=\"contraindication\">known ultra-rapid codeine metabolisers</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48952\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/co-codamol\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Acute abdomen</ph>; <ph outputclass=\"caution\">alcohol dependence</ph>; <ph outputclass=\"caution\">avoid abrupt withdrawal after long-term treatment</ph>; <ph outputclass=\"caution\">cardiac arrhythmias</ph>; <ph outputclass=\"caution\">chronic alcoholism</ph>; <ph outputclass=\"caution\">chronic dehydration</ph>; <ph outputclass=\"caution\">chronic malnutrition</ph>; <ph outputclass=\"caution\">convulsive disorders</ph>; <ph outputclass=\"caution\">gallstones</ph>; <ph outputclass=\"caution\">hepatocellular insufficiency</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Variation in metabolism</p>\n<p>The capacity to metabolise codeine to morphine can vary considerably between individuals; there is a marked increase in morphine toxicity in patients who are ultra-rapid codeine metabolisers (CYP2D6 ultra-rapid metabolisers) and a reduced therapeutic effect in poor codeine metabolisers.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48870\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/co-codamol\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (paracetamol).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48811\" outputclass=\"sideEffects\" rev=\"1.18\" parent=\"/drugs/co-codamol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">depression (with larger doses)</ph>; <ph outputclass=\"sideEffect\">hypothermia</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">muscle fasciculation</ph>; <ph outputclass=\"sideEffect\">neutropenia</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">seizures</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p>\n<b>Important:</b> liver damage (and less frequently renal damage) following overdosage with paracetamol.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48968\" outputclass=\"breastFeeding\" parent=\"/drugs/co-codamol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;although amount of codeine usually too small to be harmful, mothers vary considerably in their capacity to metabolise codeine&#8212;risk of morphine overdose in infant.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48887\" outputclass=\"hepaticImpairment\" parent=\"/drugs/co-codamol\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Dose-related toxicity with paracetamol&#8212;avoid large doses.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48828\" outputclass=\"renalImpairment\" parent=\"/drugs/co-codamol\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Reduce dose or avoid codeine; increased and prolonged effect; increased cerebral sensitivity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57497\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.14\" parent=\"/drugs/co-codamol\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Co-codamol is a mixture of codeine phosphate and paracetamol; the proportions are expressed in the form x/y, where x and y are the strengths in milligrams of codeine phosphate and paracetamol respectively.</p>\n<p>When co-codamol tablets, dispersible (or effervescent) tablets, or capsules are prescribed and <b>no strength is stated</b>, tablets, dispersible (or effervescent) tablets, or capsules, respectively, containing codeine phosphate <b>8&#8239;mg</b> and paracetamol <b>500&#8239;mg</b> should be dispensed.</p>\n<p>The Drug Tariff allows tablets of co-codamol labelled &#8216;dispersible&#8217; to be dispensed against an order for &#8216;effervescent&#8217; and <i>vice versa</i>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35182\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.11\" parent=\"/drugs/co-codamol\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Co-codamol is less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35165\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.10\" parent=\"/drugs/co-codamol\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p>Co-codamol 8/500 can be sold to the public in certain circumstances; for exemptions see<i> Medicines, Ethics and Practice,</i> London, Pharmaceutical Press (always consult latest edition).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2610-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/co-codamol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77391\" title=\"Tablet\" namespace=\"/drugs/co-codamol/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77412\" title=\"Effervescent tablet\" namespace=\"/drugs/co-codamol/effervescent-tablet\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77418\" title=\"Capsule\" namespace=\"/drugs/co-codamol/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_59\" namespace=\"/interactions/list-of-drug-interactions/analgesics/paracetamol\" title=\"Paracetamol\" count=\"1\" rel=\"link\">Paracetamol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_88\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/codeine\" title=\"Codeine\" count=\"1\" rel=\"link\">Codeine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" namespace=\"/drug-classes/opioids\" title=\"OPIOIDS\" count=\"1\" rel=\"link\">OPIOIDS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP460\" namespace=\"/drugs/codeine-phosphate\" title=\"CODEINE PHOSPHATE\" count=\"1\" rel=\"link\">CODEINE PHOSPHATE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77391\" namespace=\"/drugs/co-codamol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77412\" namespace=\"/drugs/co-codamol/effervescent-tablet\" title=\"Effervescent tablet\" count=\"1\" rel=\"link\">Effervescent tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77418\" namespace=\"/drugs/co-codamol/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP2610",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/co-codamol",
    "basename": "co-codamol",
    "title": "CO-CODAMOL",
    "interactants": [
        {
            "id": "bnf_int_59",
            "label": "Paracetamol"
        },
        {
            "id": "bnf_int_88",
            "label": "Codeine"
        }
    ],
    "vtmid": "412556009",
    "drugClassification": [
        "Opioids"
    ],
    "inheritsFromClass": [
        "OPIOIDS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate pain (using co-codamol 8/500 preparations only)",
                        "html": "Mild to moderate pain (using co-codamol 8/500 preparations only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "8/500&#8211;16/1000 mg every 4&#8211;6 hours as required; maximum 64/4000 mg per day.",
                        "html": "<p>8/500&#8211;16/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 64/4000&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate pain (using co-codamol 15/500 preparations only)",
                        "html": "Mild to moderate pain (using co-codamol 15/500 preparations only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "15/500&#8211;30/1000 mg every 4&#8211;6 hours as required; maximum 120/4000 mg per day.",
                        "html": "<p>15/500&#8211;30/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 120/4000&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe pain (using co-codamol 30/500 preparations only)",
                        "html": "Severe pain (using co-codamol 30/500 preparations only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "30/500&#8211;60/1000 mg every 4&#8211;6 hours as required; maximum 240/4000 mg per day.",
                        "html": "<p>30/500&#8211;60/1000&#8239;mg every 4&#8211;6&#8239;hours as required; maximum 240/4000&#8239;mg per day.</p>"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "references": [
                    {
                        "id": "PHP460",
                        "label": "codeine phosphate"
                    }
                ],
                "textContent": "See codeine phosphate for MHRA/CHM advice for restrictions on the use of codeine as an analgesic in children.",
                "html": "<p>See <xref format=\"dita\" href=\"#PHP460\" type=\"drug\" namespace=\"/drugs/codeine-phosphate\">codeine phosphate</xref> for MHRA/CHM advice for restrictions on the use of codeine as an analgesic in children.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute ulcerative colitis",
                "html": "Acute ulcerative colitis"
            },
            {
                "type": "contraindications",
                "textContent": "antibiotic-associated colitis",
                "html": "antibiotic-associated colitis"
            },
            {
                "type": "contraindications",
                "textContent": "children under 18 years who undergo the removal of tonsils or adenoids for the treatment of obstructive sleep apnoea",
                "html": "children under 18 years who undergo the removal of tonsils or adenoids for the treatment of obstructive sleep apnoea"
            },
            {
                "type": "contraindications",
                "textContent": "conditions where abdominal distention develops",
                "html": "conditions where abdominal distention develops"
            },
            {
                "type": "contraindications",
                "textContent": "conditions where inhibition of peristalsis should be avoided",
                "html": "conditions where inhibition of peristalsis should be avoided"
            },
            {
                "type": "contraindications",
                "textContent": "known ultra-rapid codeine metabolisers",
                "html": "known ultra-rapid codeine metabolisers"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute abdomen",
                "html": "Acute abdomen"
            },
            {
                "type": "cautions",
                "textContent": "alcohol dependence",
                "html": "alcohol dependence"
            },
            {
                "type": "cautions",
                "textContent": "avoid abrupt withdrawal after long-term treatment",
                "html": "avoid abrupt withdrawal after long-term treatment"
            },
            {
                "type": "cautions",
                "textContent": "cardiac arrhythmias",
                "html": "cardiac arrhythmias"
            },
            {
                "type": "cautions",
                "textContent": "chronic alcoholism",
                "html": "chronic alcoholism"
            },
            {
                "type": "cautions",
                "textContent": "chronic dehydration",
                "html": "chronic dehydration"
            },
            {
                "type": "cautions",
                "textContent": "chronic malnutrition",
                "html": "chronic malnutrition"
            },
            {
                "type": "cautions",
                "textContent": "convulsive disorders",
                "html": "convulsive disorders"
            },
            {
                "type": "cautions",
                "textContent": "gallstones",
                "html": "gallstones"
            },
            {
                "type": "cautions",
                "textContent": "hepatocellular insufficiency",
                "html": "hepatocellular insufficiency"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Variation in metabolism",
                "textContent": "The capacity to metabolise codeine to morphine can vary considerably between individuals; there is a marked increase in morphine toxicity in patients who are ultra-rapid codeine metabolisers (CYP2D6 ultra-rapid metabolisers) and a reduced therapeutic effect in poor codeine metabolisers.",
                "html": "<p>The capacity to metabolise codeine to morphine can vary considerably between individuals; there is a marked increase in morphine toxicity in patients who are ultra-rapid codeine metabolisers (CYP2D6 ultra-rapid metabolisers) and a reduced therapeutic effect in poor codeine metabolisers.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (paracetamol).",
                "html": "<p>Appendix 1 (paracetamol).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression (with larger doses)",
                        "html": "depression (with larger doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypothermia",
                        "html": "hypothermia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle fasciculation",
                        "html": "muscle fasciculation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "neutropenia",
                        "html": "neutropenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "seizures",
                        "html": "seizures",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "textContent": "Important: liver damage (and less frequently renal damage) following overdosage with paracetamol.",
                "html": "<p>\n<b>Important:</b> liver damage (and less frequently renal damage) following overdosage with paracetamol.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;although amount of codeine usually too small to be harmful, mothers vary considerably in their capacity to metabolise codeine&#8212;risk of morphine overdose in infant.",
                "html": "<p>Avoid&#8212;although amount of codeine usually too small to be harmful, mothers vary considerably in their capacity to metabolise codeine&#8212;risk of morphine overdose in infant.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Dose-related toxicity with paracetamol&#8212;avoid large doses.",
                "html": "<p>Dose-related toxicity with paracetamol&#8212;avoid large doses.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Reduce dose or avoid codeine; increased and prolonged effect; increased cerebral sensitivity.",
                "html": "<p>Reduce dose or avoid codeine; increased and prolonged effect; increased cerebral sensitivity.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Co-codamol is a mixture of codeine phosphate and paracetamol; the proportions are expressed in the form x/y, where x and y are the strengths in milligrams of codeine phosphate and paracetamol respectively.\n\nWhen co-codamol tablets, dispersible (or effervescent) tablets, or capsules are prescribed and no strength is stated, tablets, dispersible (or effervescent) tablets, or capsules, respectively, containing codeine phosphate 8 mg and paracetamol 500 mg should be dispensed.\n\nThe Drug Tariff allows tablets of co-codamol labelled &#8216;dispersible&#8217; to be dispensed against an order for &#8216;effervescent&#8217; and vice versa.",
                "html": "<p>Co-codamol is a mixture of codeine phosphate and paracetamol; the proportions are expressed in the form x/y, where x and y are the strengths in milligrams of codeine phosphate and paracetamol respectively.</p><p>When co-codamol tablets, dispersible (or effervescent) tablets, or capsules are prescribed and <b>no strength is stated</b>, tablets, dispersible (or effervescent) tablets, or capsules, respectively, containing codeine phosphate <b>8&#8239;mg</b> and paracetamol <b>500&#8239;mg</b> should be dispensed.</p><p>The Drug Tariff allows tablets of co-codamol labelled &#8216;dispersible&#8217; to be dispensed against an order for &#8216;effervescent&#8217; and <i>vice versa</i>.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Co-codamol is less suitable for prescribing.",
                "html": "<p>Co-codamol is less suitable for prescribing.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "textContent": "Co-codamol 8/500 can be sold to the public in certain circumstances; for exemptions see Medicines, Ethics and Practice, London, Pharmaceutical Press (always consult latest edition).",
                "html": "<p>Co-codamol 8/500 can be sold to the public in certain circumstances; for exemptions see<i> Medicines, Ethics and Practice,</i> London, Pharmaceutical Press (always consult latest edition).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77391",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77412",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77418",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_59",
                "label": "Paracetamol",
                "type": "interaction"
            },
            {
                "id": "bnf_int_88",
                "label": "Codeine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34573",
                "label": "OPIOIDS",
                "type": "drugClass"
            }
        ],
        "drug": [
            {
                "id": "PHP460",
                "label": "CODEINE PHOSPHATE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77391",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77412",
                "label": "Effervescent tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77418",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}